CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (6,196)	$ (3,218)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense	868	952
Depreciation and amortization	984	721
Deferred income taxes	(2,387)	(1,520)
Gain on the sale of fixed assets	0	(8)
Foreign currency transaction losses	165	175
Gain on forgiveness of long-term debt	0	(2,173)
Changes in operating assets and liabilities:
Accounts receivable	(6,343)	(3,124)
Inventories	(3,551)	4,677
Prepaid income taxes	(51)	(110)
Other current and long-term assets	(137)	(213)
Accounts payable	1,926	(241)
Accrued liabilities and other liabilities	508	143
Net cash used in operating activities	(14,214)	(3,939)
Cash flows from investing activities:
Capital expenditures	(955)	(804)
Proceeds from the sale of fixed assets	0	8
Collection of note receivable	0	1,598
Net cash (used in) provided by investing activities	(955)	802
Cash flows from financing activities:
Proceeds from the issuance of common stock	0	12,214
Proceeds from bank borrowings	2,250	0
Payment of common stock issuance costs	0	(867)
Proceeds from stock option exercises	0	284
Withholding taxes paid on stock issuances	(119)	(100)
Payment of bank financing costs	(69)	(31)
Net cash provided by financing activities	2,062	11,500
Effect of exchange rate changes on cash and cash equivalents	14	(64)
(Decrease) increase in cash and cash equivalents	(13,093)	8,299
Cash and cash equivalents, beginning of period	19,457	10,359
Cash and cash equivalents, end of period	$ 6,364	$ 18,658